tuberculum sellae meningioma

鞍结节脑膜瘤
  • 文章类型: Case Reports
    需要干预的独特病因并存的颅内病理很少见。文献中仅报道了少数病例。在管理期间需要考虑每种治疗方案对两种病理的影响。我们描述了并发症状性sellae结节脑膜瘤(TSM)和特发性颅内高压(IIH)的患者的管理的第一份报告。
    一名58岁男性出现2周视力下降和3个月的头痛。他被发现左眼和双侧乳头水肿有下半视野缺损。影像学检查显示双侧横窦狭窄和TSM邻接左视神经。开启压力为40cmH2O。进行了扩大的鼻内镜入路进行肿块切除。术中,在获得明确治疗之前,放置了腰椎引流管以帮助颅底修复完整性。术后第9天,放置右侧横乙状窦支架进行IIH治疗。患者第二天出院。
    我们对该患者的治疗针对每种症状病理的病因。支架术为IIH提供了治疗,并为视力丧失提供了大量切除。认为治疗的顺序和方法都可以最大程度地提高患者的利益,同时最大程度地减少伤害。
    UNASSIGNED: Coexisting intracranial pathologies of distinct etiology which require intervention are rare. Only a handful of cases have been reported in the literature. The effects of each treatment option on both pathologies need to be considered during management. We describe the first report of the management of a patient with concurrent symptomatic tuberculum sellae meningioma (TSM) and idiopathic intracranial hypertension (IIH).
    UNASSIGNED: A 58-year-old male presented with 2 weeks of vision loss and 3 months of headaches. He was found to have an inferior hemi-field deficit in the left eye and bilateral papilledema. Imaging studies revealed bilateral transverse sinus stenosis and a TSM abutting the left optic nerve. The opening pressure was 40 cmH2O. An expanded-endoscopic endonasal approach was performed for mass resection. Intraoperatively, a lumbar drain was placed to aid skull base repair integrity before definitive treatment was obtained. On postoperative day 9, a right transverse-sigmoid sinus stent was placed for IIH treatment. The patient was discharged the following day.
    UNASSIGNED: Our management of this patient targeted the etiologies of each symptomatic pathology. Stenting provided treatment for the IIH and mass resection for the vision loss. Both the order and approaches to treatment were felt to maximize patient benefit while minimizing harm.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本研究比较了内镜经鼻入路(EEA)与常规经颅入路(TCA)治疗鞍区脑膜瘤(TSM)的有效性,旨在确定优越的手术方法和影响预后的危险因素。
    方法:对1998年至2023年在我们机构接受TSM治疗的患者进行了回顾性分析,评估患者特征,肿瘤特征,结果,和并发症。还提出了一种用于TSM术前评估的新型分级系统。
    结果:在49例患者中,26例接受EEA和23例TCA。两组之间的最大直径相当(平均值,22毫米vs.23毫米,分别)。EEA的总切除率(GTR)为62%,TCA为70%,没有显着差异。然而,与TCA组相比,EEA组的术后视觉改善明显高于TCA组(77%vs.44%;p=0.020),EEA组并发症较少(8%vs.35%;p=0.032)。
    结论:EEA为中小型TSM提供了安全有效的治疗方法,在切除方面与TCA相当,但视力改善和并发症少。手术入路的选择应考虑患者和肿瘤的特点,随着外科医生的经验。
    OBJECTIVE: This study compared the effectiveness of the endoscopic endonasal approach (EEA) with the conventional transcranial approach (TCA) for treating tuberculum sellae meningiomas (TSMs), aiming to identify the superior surgical method and the risk factors affecting outcomes.
    METHODS: Patients treated for TSM from 1998 to 2023 at our institution were retrospectively analyzed, evaluating patient characteristics, tumor features, outcomes, and complications. A novel grading system for preoperative evaluation of TSMs was proposed.
    RESULTS: Among 49 patients, 26 underwent EEA and 23 underwent TCA. The maximum diameters were comparable between the groups (mean 22 mm vs. 23 mm). Gross total resection rates were 62% for EEA and 70% for TCA, showing no significant difference. However, postsurgical visual improvement was significantly higher in the EEA group compared with the TCA group (77% vs. 44%; P = 0.020), with fewer complications in the EEA group (8% vs. 35%; P = 0.032).
    CONCLUSIONS: EEA is a safe and effective treatment approach for small to medium TSMs, with outcomes comparable to TCA in terms of resection but superior in visual improvement and fewer complications. Selection of surgical approach should consider patient and tumor characteristics as well as surgeon experience.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景/目的:鞍区脑膜瘤(TSM)占颅内脑膜瘤的5-10%,经常导致视力障碍。传统的显微外科经颅手术(MTA)是有效的,但是创新手术轨迹的出现,例如鼻内镜入路(EEA),引发了辩论。虽然EEA提供了减少大脑收缩的优势,它们与更高的脑脊液漏(CSF漏)风险有关。这项荟萃分析旨在全面比较EEA和MTA切除TSM的疗效和安全性,提供对各自结果和并发症的见解。方法:对PubMed数据库进行全面的文献综述,OvidMEDLINE,和OvidEMBASE在2024年之前在接受EEA或MTA治疗的TSM上发表的文章进行了研究。根据系统评价的首选报告项目和荟萃分析指南进行系统评价。进行荟萃分析以估计合并事件发生率并评估异质性。固定和随机效应用于评估出现症状的95%保密间隔(CI),结果,和并发症。结果:初步确定论文291篇,其中2000年至2024年的18项研究符合纳入标准。排除180篇文章是由于不相关等原因,未报告选定的结果,系统文献综述或荟萃分析,缺乏方法/结果的细节。18项研究共包括1093例患者:444例接受EEA的患者和649例接受MTA的TSM。总切除率(GTR)从EEA的80.9%到MTA的79.8%不等。EEA组为86.6%,MTA组为65.4%。EEA组的复发率为6.9%,而MTA组为5.1%。术后并发症分析为脑脊液漏,感染,功能障碍,颅内出血(ICH),和内分泌失调。EEA组的CSF泄漏率为9.8%,MTA组为2.1%。EEA组感染率为5.7%,而MTA组为3.7%。运动障碍的发生率从MTA的10.3%到EEA的12.9%不等。EEA组ICH发生率为0.9%,而MTA组为3.8%。EEA组内分泌紊乱率为10.8%,而MTA组为10.2%。EEA组和MTA组之间的GTR率无显着差异(OR1.15,95%CI0.7-0.95;p=0.53),而EEA显示了视觉结局的显着益处(OR3.54,95%CI2.2-5.72;p<0.01)。EEA组和MTA组之间的复发率没有显着差异(OR0.92,95%CI0.19-4.46;p=0.89)。虽然显示EEA的CSF泄漏机会大大增加(OR4.47,95%CI2.52-7.92;p<0.01),EEA和MTA组的感染率没有显着差异(OR1.92,95%CI0.73-5.06;p=0.15),功能障碍率(OR1.25,95%CI0.31-4.99;p=0.71),脑出血率(OR0.61,95%CI0.20-1.87;p=0.33),和内分泌失调的发生率(OR1.16,95%CI0.69-1.95;p=0.53)。结论:这项荟萃分析表明,EEA和MTA都是TSM切除术的可行选择,具有明显的优点和缺点。EEA在选定病例中表现出优异的视力结果,而GTR和复发率支持MTA和EEA的整体有效性。内镜经鼻入路脑脊液漏的机率较高,但是其他并发症没有明显的变化。这些结果提供了有关TSM复杂临床环境中患者结果的其他见解。
    Background/Objectives: Tuberculum sellae meningiomas (TSMs) constitute 5-10% of intracranial meningiomas, often causing visual impairment. Traditional microsurgical transcranial approaches (MTAs) have been effective, but the emergence of innovative surgical trajectories, such as endoscopic endonasal approaches (EEAs), has sparked debate. While EEAs offer advantages like reduced brain retraction, they are linked to higher cerebrospinal fluid leak (CSF leak) risk. This meta-analysis aims to comprehensively compare the efficacy and safety of EEAs and MTAs for the resection of TSMs, offering insights into their respective outcomes and complications. Methods: A comprehensive literature review of the databases PubMed, Ovid MEDLINE, and Ovid EMBASE was conducted for articles published on TSMs treated with either EEA or MTA until 2024. The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Meta-analysis was performed to estimate pooled event rates and assess heterogeneity. Fixed- and random-effects were used to assess 95% confidential intervals (CIs) of presenting symptoms, outcomes, and complications. Results: A total of 291 papers were initially identified, of which 18 studies spanning from 2000 to 2024 met the inclusion criteria. The exclusion of 180 articles was due to reasons such as irrelevance, non-reporting of selected results, systematic literature review or meta-analysis, and a lack of details on method/results. The 18 studies comprised a total sample of 1093 patients: 444 patients who underwent EEAs and 649 patients who underwent MTAs for TSMs. Gross total resection (GTR) rates ranged from 80.9% for EEAs to 79.8% for MTAs. The rate of visual improvement was 86.6% in the EEA group and 65.4% in the MTA group. The recurrence rate in the EEA group was 6.9%, while it was 5.1% in MTA group. The postoperative complications analyzed were CSF leak, infections, dysosmia, intracranial hemorrhage (ICH), and endocrine disorders. The rate of CSF leak was 9.8% in the EEA group and 2.1% in MTA group. The rate of infections in the EEA group was 5.7%, while it was 3.7% in the MTA group. The rate of dysosmia ranged from 10.3% for MTAs to 12.9% for EEAs. The rate of ICH in the EEA group was 0.9%, while that in the MTA group was 3.8%. The rate of endocrine disorders in the EEA group was 10.8%, while that in the MTA group was 10.2%. No significant difference was detected in the rate of GTR between the EEA and MTA groups (OR 1.15, 95% CI 0.7-0.95; p = 0.53), while a significant benefit in visual outcomes was shown in EEAs (OR 3.54, 95% CI 2.2-5.72; p < 0.01). There was no significant variation in the recurrence rate between EEA and MTA groups (OR 0.92, 95% CI 0.19-4.46; p = 0.89). While a considerably increased chance of CSF leak from EEAs was shown (OR 4.47, 95% CI 2.52-7.92; p < 0.01), no significant difference between EEA and MTA groups was detected in the rate of infections (OR 1.92, 95% CI 0.73-5.06; p = 0.15), the rate of dysosmia (OR 1.25, 95% CI 0.31-4.99; p = 0.71), the rate of ICH (OR 0.61, 95% CI 0.20-1.87; p = 0.33), and the rate of endocrine disorders (OR 1.16, 95% CI 0.69-1.95; p = 0.53). Conclusions: This meta-analysis suggests that both EEAs and MTAs are viable options for TSM resection, with distinct advantages and drawbacks. The EEAs demonstrate superior visual outcomes in selected cases while GTR and recurrence rates support the overall effectiveness of MTAs and EEAs. Endoscopic endonasal approaches had a higher chance of CSF leaks, but there are no appreciable variations in other complications. These results provide additional insights regarding patient outcomes in the intricate clinical setting of TSMs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    鞍结节脑膜瘤通常表现为双颞侧偏视,视神经压迫导致视力丧失。两名女性患者(48岁和58岁)由于鞍结节脑膜瘤(25和10毫米,分别)。尽管他们的视野缺陷不是很大,日常活动,包括走路或阅读受到阻碍。通过完全切除两名患者的肿瘤,暗点被治愈,日常活动恢复。当患者表现出视觉缺陷时,尤其是在较低的中心领域,即使肿瘤很小且视力缺陷有限,也应考虑手术切除,因为可以改善视力和日常活动。
    Tuberculum sellae meningiomas commonly present as bitemporal hemianopia and loss of visual acuity due to optic nerve compression. Two female patients (48 and 58 years old) presented with a small scotoma at the lower visual field center due to tuberculum sellae meningioma (25 and 10 mm, respectively). Despite the fact that their visual field defect was not very large, daily activities, including walking or reading were hindered. By the total removal of the tumors in both patients, the scotoma was cured and daily activities recovered. When patients exhibit visual deficits, especially in the lower center fields, surgical removal should be considered even if the tumors are small and visual deficits are limited because improvement of both vision and daily activities can be achieved.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Review
    背景:sellae(TS)脑膜瘤是前颅底最常见的脑膜瘤之一。在此,我们对有关TS脑膜瘤的首选手术方法的文献进行了回顾;此外,我们描述了两个说明性的案例,由我们小组使用不同的方法进行操作,目的是严格修改手术适应症和禁忌症。
    方法:2021年10月,在罗马的PoliclinicoGemelli治疗了两名女性鞍结节脑膜瘤患者。患者出现视力恶化。采用额颞入路和经蝶入路进行手术。评估手术前后的视功能是这些肿瘤手术治疗的主要结果参数。
    结论:经颅入路和经蝶入路可以安全地切除鞍区脑膜瘤,并保留甚至改善术后视觉功能。肿瘤与视神经的关系,视神经管,和大脑前动脉复合体是处理鞍结节脑膜瘤时必须考虑的重要问题。经颅和鼻内入路,在有经验的手中,可以完全切除病变。
    BACKGROUND: Tuberculum sellae (TS) meningioma is one of the most frequent meningiomas of the anterior skull base. Herein we perform a review of the literature concerning the preferred surgical approaches to TS meningiomas; in addition, we describe two explicative cases, operated on by our group using different approaches, with the aim to critically revise surgical indications and contraindications.
    METHODS: In October 2021, two female patients with tuberculum sellae meningioma were treated at the Policlinico Gemelli of Rome. The patients presented with visual deterioration. Surgery was performed using the fronto-temporal approach and transsphenoidal approach. The visual function before and after surgery was evaluated as the main outcome parameter of the surgical treatment of these tumors.
    CONCLUSIONS: Tuberculum sellae meningioma can be safely resected using the transcranial approach and the transsphenoidal endoscopic approach with preservation and even improvement of visual function after surgery. The relationship of the tumor with the optic nerves, optic canal, and anterior cerebral artery complex are important issues that have to be considered when dealing with tuberculum sellae meningioma. Both transcranial and endonasal approaches, in experienced hands, can allow complete resection of the lesion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:鞍区脑膜瘤(TSM)通常位于视神经和视交叉附近,因此,手术的主要目的是增强或稳定患者的视力。因此,作者对他们17年的翼状入路经验进行了回顾性回顾,以确定切除率。神经系统的结果,和视觉结果。
    方法:对2003年9月至2020年12月在作者机构接受TSM手术的患者进行回顾性评估。患者人口统计学,肿瘤特征,手术参数,术后视觉结果,并对并发症进行分析。评估总切除率(GTR)和次全切除率(STR),以及手术入路对视觉结果的影响。
    结果:共有71名平均年龄为56.9±14.3岁的患者被纳入研究。平均肿瘤体积为10.2±12.8cm3。术后,38.7%的患者经历了视觉改善,45.2%视力稳定,16.1%显示视力下降。同侧或对侧手术方法是根据受影响最大的视力进行的。两种方法在术后视觉结果上没有观察到显着差异。GTR达到84.0%,STR达到16.0%。3例患者发生轻微并发症(4.2%),4例(5.6%)出现严重并发症。7例患者(9.8%)在53个月后出现复发性肿瘤生长。GTR后无进展生存期为123.9±12.9个月,STR后59.3±13.2个月。
    结论:这项研究强调了这样一个发现,即使用经颅翼点入路可以成功切除TSM,并发症风险低,视力结果充分。有必要进行更大样本量的进一步研究,以证实这些发现并优化TSM切除术的手术策略。
    OBJECTIVE: Tuberculum sellae meningiomas (TSMs) are typically in the proximity of the optic nerves and the optic chiasm, thus making the primary aim of surgery the enhancement or stabilization of the patients\' visual acuity. The authors therefore undertook a retrospective review of their 17-year experience with the pterional approach to ascertain the resection rate, neurological outcome, and visual outcome.
    METHODS: Patients who underwent TSM surgery between September 2003 and December 2020 at the authors\' institution were retrospectively evaluated. Patient demographics, tumor characteristics, surgical parameters, postoperative visual outcomes, and complications were analyzed. Gross-total resection (GTR) and subtotal resection (STR) rates were assessed, along with the impact of surgical approach on visual outcomes.
    RESULTS: A total of 71 patients with a mean age of 56.9 ± 14.3 years were enrolled in the study. The mean tumor volume was 10.2 ± 12.8 cm3. Postoperatively, 38.7% of patients experienced visual improvement, 45.2% had stable visual acuity, and 16.1% showed visual deterioration. Ipsilateral or contralateral surgical approaches were performed based on the side of the most affected visual acuity. No significant difference in postoperative visual outcomes was observed between the two approaches. GTR was achieved in 84.0% and STR in 16.0%. Minor complications occurred in 3 patients (4.2%), while major complications were found in 4 patients (5.6%). Seven patients (9.8%) showed recurrent tumor growth after 53 months. Progression-free survival after GTR was 123.9 ± 12.9 months, and it was 59.3 ± 13.2 months after STR.
    CONCLUSIONS: This study highlighted the finding that TSMs can be successfully resected using a transcranial pterional approach with a low risk of complications and sufficient visual outcomes. Further studies with larger sample sizes are warranted to confirm these findings and optimize surgical strategies for TSM resection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Tuberculum sellae meningioma (TSM) is a challenging tumor that grows close to several crucial structures, such as the optic nerve, arteries, and pituitary. Surgical treatment is currently evolving from a transcranial microsurgical resection to a transsphenoidal approach. This study examined the clinical profile of patients with tuberculum sellae meningioma and explored its relationship with scoring systems. This retrospective observational study included patients with TSM who underwent surgery at the Department of Neurosurgery at our hospital between 2017 and 2022. The patients were excluded if their data required completion. The clinical profiles of the patients were counted and transformed into a scoring system using several variables such as size, vascular, and canal invasion. We then analyzed the relationship between the clinical signs and symptoms to determine the efficacy of this scoring system. Thirty-six patients were included in the study. Most of our patients had a high score for tumor diameter, bilateral canal invasion, and vascular invasion (2-2-2). Moreover, when related to clinical signs, there was no relationship between the canal and vascular invasion and decreased visual acuity. Tuberculum sellae meningioma mostly causes visual impairment and several other symptoms, such as hemianopsia and parasellar extension. Several factors in the scoring system should also be considered to predict outcomes, such as the onset of visual symptoms, peritumoral edema, and grade of excision.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:鞍区脑膜瘤(TSM)是一种复杂的颅底肿瘤。手术治疗的主要目标是最大程度的安全切除和视觉恢复;因此,适当的患者选择对于优化结果至关重要.在过去的20年里,鼻内镜入路(EEA)已成为治疗这些肿瘤的一种成功且可行的策略.作者确定了与TSM的EEA切除程度和视觉结果相关的术前因素。
    方法:在这项回顾性队列研究中,作者分析了2005年1月至2022年4月在神经外科期间接受了TSM内镜下鼻内手术的患者,那不勒斯费德里科第二大学,那不勒斯,意大利。肿瘤大小,船只外壳,视神经管受累根据加州大学进行分类,旧金山,得分。根据视觉障碍评分(VIS)分析视力和视野,定义为四级分类:1级(VIS0-25),2级(VIS26-50),3级(VIS51-75),和4级(VIS76-100)。术前和术后早期(术后6个月内)和术后晚期测试了眼科功能。
    结果:共纳入48例患者。41例(85.4%)患者出现视力模糊或视野缺损。40例(83.3%)实现了大体全切除,2例(4.2%)几乎全部切除,6次全切除(12.5%)。视力缺损改善82.9%(34/41),12.2%(5/41)无明显变化,2.4%(1/41)的患者视力缺损恶化。VIS的平均变化为42%(95%CI58.77-31.23)。当术前VIS(VIS-pre)大于25时,视觉结果较差(p=0.02)。术后发生6例脑脊液漏(12.5%),1例患者(2.1%)需要翻修手术.
    结论:EEA是一种安全有效的TSM去除方法,具有保留光学装置血管化的优势,并能促进大体全切除和视力改善。作者根据与术后结果相关的VIS定义了四个类别:VIS-pre越低,术后VIS改善率越高。这一发现对于预测患者在术前阶段的视觉结果可能是有用的。
    OBJECTIVE: Tuberculum sellae meningioma (TSM) represents a complex skull base tumor. The primary goals of surgical treatment are represented by maximal safe resection and visual recovery; therefore, appropriate patient selection is critical to optimize results. In the last 2 decades, the endoscopic endonasal approach (EEA) has appeared as a successful and viable strategy for the management of these tumors. The authors identified preoperative factors associated with extent of resection and visual outcome after EEA for TSM.
    METHODS: In this retrospective cohort study, the authors analyzed patients who underwent extended endoscopic endonasal surgery for TSM between January 2005 and April 2022 at the Division of Neurosurgery, Università degli Studi di Napoli Federico II, Naples, Italy. Tumor size, vessel encasement, and optic canal involvement were classified according to University of California, San Francisco, score. Visual acuity and visual fields were analyzed according to the visual impairment score (VIS), defined as a four-level classification: grade 1 (VIS 0-25), grade 2 (VIS 26-50), grade 3 (VIS 51-75), and grade 4 (VIS 76-100). Ophthalmological functions were tested preoperatively and during the early postoperative period (within 6 months after surgery) and late postoperative period.
    RESULTS: A total of 48 patients were enrolled. Forty-one (85.4%) patients experienced blurred vision or visual field defect as a presenting sign. Gross-total resection was achieved in 40 (83.3%), near-total resection in 2 (4.2%), and subtotal resection in 6 (12.5%). Visual defect improved in 82.9% (34/41) of cases, 12.2% (5/41) had no significant changes, and 2.4% (1/41) had worsened visual defect. The mean change in VIS was 42% (95% CI 58.77-31.23). Visual outcome was poorer when preoperative VIS (VIS-pre) was greater than 25 (p = 0.02). Six postoperative CSF leaks occurred (12.5%), and 1 patient (2.1%) required revision surgery.
    CONCLUSIONS: The EEA is a safe and effective approach for TSM removal, with the advantage of preserving optic apparatus vascularization, and can promote gross-total resection and visual improvement. The authors have defined four categories based on VIS that relate to postoperative outcome: the lower the VIS-pre, the higher the rate of postoperative VIS improvement. This finding may be useful for predicting a patient\'s visual outcome at the preoperative stage.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Meta-Analysis
    视管去顶(OCU)已逐渐成为结结节脑膜瘤(TSM)切除的常规技术。本荟萃分析旨在评估OCU的有效性和安全性。根据PRISMA指南,对2003年至2023年有关该主题的已发表文献进行了系统回顾和荟萃分析。对视觉改善的相关变化进行了p值的严格统计分析,总切除(GTR),视觉恶化,和嗅神经损伤.该研究包括15篇文章,其中384例患者通过经颅入路(TCA)或内镜经鼻入路(EEA)进行OCU。其中,341例患者术前视力下降,266例患者术后视力恢复。总体视力改善率为0.803(95%CI:0.733-0.874,p<0.01)。EEA和TCA组的视觉改善率分别为0.884(95%CI:0.803-0.965,p<0.01)和0.788(95%CI:0.700-0.875,p<0.01)。进一步分类分析表明,I型:<2cm的视觉改善率为0.889(95%CI:0.739-0.969),II型:2-4厘米为0.844(95%CI:0.755-0.910),III型:>4cm为0.500(95%CI:0.068-0.932),总数为0.853(95%CI:0.779-0.927p<0.01),I2的异质性低=20.80%。12项研究分别报道OCU的GTR为293;GTR率为0.911(95%CI:0.848-0.961,p<0.01)。I型:<2cm的GTR率为0.933(95%CI:0.817-0.986),II型:2-4厘米为0.880(95%CI:0.800-0.936),III型:>4cm为0.600(95%CI:0.147-0.947)。总数为0.897(95%CI:0.830-0.965p<0.01),具有I2=34.57%的低异质性。OCU的相关并发症为视力下降和嗅神经损伤。九项研究报告了视力下降,率为0.077(95%CI:0.041-0.113,p<0.01)。六项研究报告了嗅神经损伤,总体发生率为0.054(95%CI:0.019-0.090,p<0.01)。OCU可以显着恢复术前视力受损,使GTR更容易实现,这也是TSM中一种安全有效的技术。
    Optic canal unroofing (OCU) has gradually become a routine technique for tuberculum sellae meningiomas (TSMs) resection. This meta-analysis aimed to evaluate the efficacy and safety of OCU. A systematic review and meta-analysis of the published literature on this topic from 2003 to 2023 were conducted in accordance with the PRISMA guidelines. Rigorous statistical analysis with a p-value was performed for related change in visual improvement, gross total resection (GTR), visual deterioration, and olfactory nerve damage. The study included 15 articles with 384 patients in whom OCU was performed by the transcranial approach (TCA) or the endoscopic endonasal approach (EEA). Of these, 341 patients had preoperative visual loss, and 266 patients had postoperative visual recovery. The overall rate of visual improvement was 0.803 (95% CI: 0.733-0.874, p < 0.01). The rate of visual improvement in the EEA and TCA groups was 0.884 (95% CI: 0.803-0.965, p < 0.01) and 0.788 (95% CI: 0.700-0.875, p < 0.01). Further analysis of classification shows that the rate of visual improvement in Type I: < 2 cm was 0.889(95% CI: 0.739-0.969), Type II:2-4 cm was 0.844(95% CI: 0.755-0.910), Type III: > 4 cm was 0.500(95% CI: 0.068-0.932) and the total was 0.853(95% CI: 0.779-0.927 p < 0.01) with low heterogeneity of I2 = 20.80%.Twelve studies separately reported GTR with OCU was 293; the rate of GTR was 0.911 (95% CI: 0.848-0.961, p < 0.01). And the rate of GTR in Type I: < 2 cm was 0.933(95% CI: 0.817-0.986), Type II:2-4 cm was 0.880(95% CI: 0.800-0.936), Type III: > 4 cm was 0.600(95% CI: 0.147-0.947). The total was 0.897(95% CI: 0.830-0.965 p < 0.01) with low heterogeneity of I2 = 34.57%. The related complications of OCU were visual deterioration and olfactory nerve damage. Visual decline was reported in nine studies, and the rate was 0.077 (95% CI: 0.041-0.113, p < 0.01). Six studies reported olfactory nerve damage, and the overall rate was 0.054 (95% CI: 0.019-0.090, p < 0.01). OCU could significantly recover preoperative impaired vision and make GTR easier to achieve, which was also a safe and effective technique in TSM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    治疗鞍上脑膜瘤患者的目标是改善或保留视觉功能,同时实现长期肿瘤控制。我们回顾性地检查了30例鞍上脑膜瘤患者的患者和肿瘤特征以及手术和视觉结果,这些患者接受了鼻内镜切除术(15例患者)。额下(8名患者),或前半球间(7例)入路。方法选择是基于视神经管侵入的存在,血管包裹,和肿瘤扩展。视管减压和探查是关键的外科手术。在80%的病例中实现了Simpson1至3级切除。在26例预先存在视觉功能障碍的患者中,18例患者出院时视力改善(69.2%),六个(23.1%)保持不变,并恶化了两个(7.7%)。在随访期间还观察到进一步逐渐的视力恢复和/或有用视力的维持。我们提出了一种算法,用于根据术前放射学肿瘤特点选择合适的手术入路治疗鞍上脑膜瘤。该算法侧重于有效的视神经管减压和最大安全切除,可能有助于良好的视觉效果。
    The goal of treating patients with suprasellar meningioma is improving or preserving visual function while achieving long-term tumor control. We retrospectively examined patient and tumor characteristics and surgical and visual outcomes in 30 patients with a suprasellar meningioma who underwent resection via an endoscopic endonasal (15 patients), sub-frontal (8 patients), or anterior interhemispheric (7 patients) approach. Approach selection was based on the presence of optic canal invasion, vascular encasement, and tumor extension. Optic canal decompression and exploration were performed as key surgical procedures. Simpson grade 1 to 3 resection was achieved in 80% of cases. Among the 26 patients with pre-existing visual dysfunction, vision at discharge improved in 18 patients (69.2%), remained unchanged in six (23.1%), and deteriorated in two (7.7%). Further gradual visual recovery and/or maintenance of useful vision were also observed during follow-up. We propose an algorithm for selecting the appropriate surgical approach to a suprasellar meningioma based on preoperative radiologic tumor characteristics. The algorithm focuses on effective optic canal decompression and maximum safe resection, possibly contributing to favorable visual outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号